...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Zenith new VP
3
Jul 28, 2017 11:55PM
2
Jul 29, 2017 12:03AM
1
Jul 29, 2017 12:17AM
3
Jul 29, 2017 06:48PM
1
Jul 29, 2017 07:12PM
3
Jul 30, 2017 08:49AM

I am not sure there would be a correlation between good clinical results with zen 3694 and the need to hire . I would speculate that if results were subpar or horrible there wouldn't be a need for  a new VP hire. It is possible that a new hire is required as the results could be excellent and the need for further clinical trials that have been discussed in the past from other webcast

 

this hire does bode well

 

2
Jul 31, 2017 12:31AM

Jul 31, 2017 01:09AM
2
Jul 31, 2017 09:07AM

Jul 31, 2017 11:09AM

Jul 31, 2017 09:15PM

Aug 01, 2017 10:03AM
1
Aug 01, 2017 10:59AM

Aug 01, 2017 11:04AM
1
Aug 01, 2017 12:57PM
2
Aug 01, 2017 01:37PM

Aug 01, 2017 06:16PM
1
Aug 02, 2017 01:05AM

Aug 02, 2017 09:56AM
2
Aug 03, 2017 12:19PM
3
Aug 03, 2017 12:33PM
4
Aug 03, 2017 12:57PM
2
Dec 07, 2017 03:04PM
Share
New Message
Please login to post a reply